|
[1]
|
(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd Edition. Cephalalgia, 38, 1-211. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Vos, T., Abajobir, A.A., Abate, K.H., Abbafati, C., Abbas, K.M., Abd-Allah, F., et al. (2017) Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet, 390, 1211-1259. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Feigin, V.L., Nichols, E., Alam, T., Bannick, M.S., Beghi, E., Blake, N., et al. (2019) Global, Regional, and National Burden of Neurological Disorders, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18, 459-480. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Ashina, M., Katsarava, Z., Do, T.P., Buse, D.C., Pozo-Rosich, P., Özge, A., et al. (2021) Migraine: Epidemiology and Systems of Care. The Lancet, 397, 1485-1495. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Leo, A.A.P. (1947) Further Observations on the Spreading Depression of Activity in the Cerebral Cortex. Journal of Neurophysiology, 10, 409-414. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Close, L.N., Eftekhari, S., Wang, M., Charles, A.C. and Russo, A.F. (2018) Cortical Spreading Depression as a Site of Origin for Migraine: Role of CGRP. Cephalalgia, 39, 428-434. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yang, M., Ren, D., Pan, X., Li, C. and Xu, S. (2024) The Role of Astrocytes in Migraine with Cortical Spreading Depression: Protagonists or Bystanders? A Narrative Review. Pain and Therapy, 13, 679-690. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Akerman, S., Holland, P.R. and Goadsby, P.J. (2008) Mechanically-Induced Cortical Spreading Depression Associated Regional Cerebral Blood Flow Changes Are Blocked by Na+ Ion Channel Blockade. Brain Research, 1229, 27-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ayata, C., Shimizu-Sasamata, M., Lo, E.H., Noebels, J.L. and Moskowitz, M.A. (1999) Impaired Neurotransmitter Release and Elevated Threshold for Cortical Spreading Depression in Mice with Mutations in the Α1a Subunit of P/Q Type Calcium Channels. Neuroscience, 95, 639-645. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ferrari, M.D., Odink, J., Bos, K.D., Malessy, M.J.A. and Bruyn, G.W. (1990) Neuroexcitatory Plasma Amino Acids Are Elevated in Migraine. Neurology, 40, 1582-1582. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Petzold, G.C., Haack, S., von Bohlen und Halbach, O., Priller, J., Lehmann, T., Heinemann, U., et al. (2008) Nitric Oxide Modulates Spreading Depolarization Threshold in the Human and Rodent Cortex. Stroke, 39, 1292-1299. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Castillo, J., Martinez, F., Leira, R., et al. J. (1994) [Changes in Neuroexcitatory Amino Acids during and between Migraine Attacks]. Neurologia, 9, 42-45.
|
|
[13]
|
Zielman, R., Wijnen, J.P., Webb, A., Onderwater, G.L.J., Ronen, I., Ferrari, M.D., et al. (2017) Cortical glutamate in migraine. Brain, 140, 1859-1871. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Oshinsky, M.L., Sanghvi, M.M., Maxwell, C.R., Gonzalez, D., Spangenberg, R.J., Cooper, M., et al. (2012) Spontaneous Trigeminal Allodynia in Rats: A Model of Primary Headache. Headache: The Journal of Head and Face Pain, 52, 1336-1349. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Storer, R.J. and Goadsby, P.J. (1999) Trigeminovascular Nociceptive Transmission Involves N-Methyl-D-Aspartate and Non-N-Methyl-D-Aspartate Glutamate Receptors. Neuroscience, 90, 1371-1376. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ayata, C., Jin, H., Kudo, C., Dalkara, T. and Moskowitz, M.A. (2006) Suppression of Cortical Spreading Depression in Migraine Prophylaxis. Annals of Neurology, 59, 652-661. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Bolay, H., Reuter, U., Dunn, A.K., Huang, Z., Boas, D.A. and Moskowitz, M.A. (2002) Intrinsic Brain Activity Triggers Trigeminal Meningeal Afferents in a Migraine Model. Nature Medicine, 8, 136-142. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Schain, A.J., Melo-Carrillo, A., Stratton, J., Strassman, A.M. and Burstein, R. (2019) CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP’s Role in Migraine with Aura. The Journal of Neuroscience, 39, 6001-6011. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Moskowitz, M., Romero, J., Reinhard, J., Melamed, E. and Pettibone, D. (1979) Neurotransmitters and the Fifth Cranial Nerve: Is There a Relation to the Headache Phase of Migraine? The Lancet, 314, 883-885. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Mulderry, P.K., Ghatki, M.A., Spokks, R.A., Jonhs, P.M., Pierson, A.M., Hamid, Q.A., et al. (1988) Differential Expression of α-CGRP and β-CGRP by Primary Sensory Neurons and Enteric Autonomic Neurons of the Rat. Neuroscience, 25, 195-205. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Eftekhari, S., Salvatore, C.A., Calamari, A., Kane, S.A., Tajti, J. and Edvinsson, L. (2010) Differential Distribution of Calcitonin Gene-Related Peptide and Its Receptor Components in the Human Trigeminal Ganglion. Neuroscience, 169, 683-696. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Weidner, C., Klede, M., Rukwied, R., Lischetzki, G., Neisius, U., Schmelz, M., et al. (2000) Acute Effects of Substance P and Calcitonin Gene-Related Peptide in Human Skin—A Microdialysis Study. Journal of Investigative Dermatology, 115, 1015-1020. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Thomsen, L.L., Kruuse, C., Iversen, H.K. and Olesen, J. (1994) A Nitric Oxide Donor (Nitroglycerin) Triggers Genuine Migraine Attacks. European Journal of Neurology, 1, 73-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Antonova, M., Wienecke, T., Olesen, J. and Ashina, M. (2012) Prostaglandin E2 Induces Immediate Migraine-Like Attack in Migraine Patients without Aura. Cephalalgia, 32, 822-833. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Goadsby, P.J., Edvinsson, L. and Ekman, R. (1988) Release of Vasoactive Peptides in the Extracerebral Circulation of Humans and the Cat during Activation of the Trigeminovascular System. Annals of Neurology, 23, 193-196. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Goadsby, P.J., Edvinsson, L. and Ekman, R. (1990) Vasoactive Peptide Release in the Extracerebral Circulation of Humans during Migraine Headache. Annals of Neurology, 28, 183-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Goadsby, P.J. and Edvinsson, L. (1993) The Trigeminovascular System and Migraine: Studies Characterizing Cerebrovascular and Neuropeptide Changes Seen in Humans and Cats. Annals of Neurology, 33, 48-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Cernuda-Morollón, E., Larrosa, D., Ramón, C., Vega, J., Martínez-Camblor, P. and Pascual, J. (2013) Interictal Increase of CGRP Levels in Peripheral Blood as a Biomarker for Chronic Migraine. Neurology, 81, 1191-1196. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Cernuda‐Morollón, E., Martínez‐Camblor, P., Ramón, C., Larrosa, D., Serrano‐Pertierra, E. and Pascual, J. (2014) CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type a in Chronic Migraine. Headache: The Journal of Head and Face Pain, 54, 987-995. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Cernuda-Morollón, E., Ramón, C., Martínez-Camblor, P., Serrano-Pertierra, E., Larrosa, D. and Pascual, J. (2015) Onabotulinumtoxina Decreases Interictal CGRP Plasma Levels in Patients with Chronic Migraine. Pain, 156, 820-824. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Juhasz, G., Zsombok, T., Jakab, B., Nemeth, J., Szolcsanyi, J. and Bagdy, G. (2005) Sumatriptan Causes Parallel Decrease in Plasma Calcitonin Gene-Related Peptide (CGRP) Concentration and Migraine Headache during Nitroglycerin Induced Migraine Attack. Cephalalgia, 25, 179-183. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Cady, R.K., Vause, C.V., Ho, T.W., Bigal, M.E. and Durham, P.L. (2009) Elevated Saliva Calcitonin Gene‐related Peptide Levels during Acute Migraine Predict Therapeutic Response to Rizatriptan. Headache: The Journal of Head and Face Pain, 49, 1258-1266. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
May, A. and Goadsby, P.J. (2001) Substance P Receptor Antagonists in the Therapy of Migraine. Expert Opinion on Investigational Drugs, 10, 673-678. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Edvinsson, L., McCulloch, J. and Uddman, R. (1981) Substance P: Immunohistochemical Localization and Effect Upon Cat Pial Arteries in Vitro and in Situ. The Journal of Physiology, 318, 251-258. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Salter, M.W. and Henry, J.L. (1991) Responses of Functionally Identified Neurones in the Dorsal Horn of the Cat Spinal Cord to Substance P, Neurokinin A and Physalaemin. Neuroscience, 43, 601-610. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Buzzi, M.G. and Moskowitz, M.A. (1990) The Antimigraine Drug, Sumatriptan (GR43175), Selectively Blocks Neurogenic Plasma Extravasation from Blood Vessels in Dura Mater. British Journal of Pharmacology, 99, 202-206. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Pietrobon, D. and Moskowitz, M.A. (2013) Pathophysiology of Migraine. Annual Review of Physiology, 75, 365-391. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Thörn Pérez, C., Hill, R.H., Manira, A.E. and Grillner, S. (2009) Endocannabinoids Mediate Tachykinin-Induced Effects in the Lamprey Locomotor Network. Journal of Neurophysiology, 102, 1358-1365. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Miyata, A., Jiang, L., Dahl, R.D., Kitada, C., Kubo, K., Fujino, M., et al. (1990) Isolation of a Neuropeptide Corresponding to the N-Terminal 27 Residues of the Pituitary Adenylate Cyclase Activating Polypeptide with 38 Residues (PACAP38). Biochemical and Biophysical Research Communications, 170, 643-648. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Moller, K., Zhang, Y., Håkanson, R., Luts, A., Sjölund, B., Uddman, R., et al. (1993) Pituitary Adenylate Cyclase Activating Peptide Is a Sensory Neuropeptide: Immunocytochemical and Immunochemical Evidence. Neuroscience, 57, 725-732. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Jansen-Olesen, I., Baun, M., Amrutkar, D.V., Ramachandran, R., Christophersen, D.V. and Olesen, J. (2014) PACAP-38 but Not VIP Induces Release of CGRP from Trigeminal Nucleus Caudalis via a Receptor Distinct from the PAC1 Receptor. Neuropeptides, 48, 53-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Ashina, M., Hansen, J.M., Do, T.P., Melo-Carrillo, A., Burstein, R. and Moskowitz, M.A. (2019) Migraine and the Trigeminovascular System—40 Years and Counting. The Lancet Neurology, 18, 795-804. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Akerman, S. and Goadsby, P.J. (2015) Neuronal PAC1 Receptors Mediate Delayed Activation and Sensitization of Trigeminocervical Neurons: Relevance to Migraine. Science Translational Medicine, 7, 308ra157. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Körtési, T., Tuka, B., Nyári, A., Vécsei, L. and Tajti, J. (2019) The Effect of Orofacial Complete Freund’s Adjuvant Treatment on the Expression of Migraine-Related Molecules. The Journal of Headache and Pain, 20, Article No. 43. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Pedersen, S.H., la Cour, S.H., Calloe, K., Hauser, F., Olesen, J., Klaerke, D.A., et al. (2019) PACAP-38 and PACAP (6-38) Degranulate Rat Meningeal Mast Cells via the Orphan MRGB3-Receptor. Frontiers in Cellular Neuroscience, 13, Article 114. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Ernstsen, C., Christensen, S.L., Rasmussen, R.H., Nielsen, B.S., Jansen-Olesen, I., Olesen, J., et al. (2022) The PACAP Pathway Is Independent of CGRP in Mouse Models of Migraine: Possible New Drug Target? Brain, 145, 2450-2460. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Hanci, F., Kilinc, Y.B., Kilinc, E., Turay, S., Dilek, M. and Kabakus, N. (2020) Plasma Levels of Vasoactive Neuropeptides in Pediatric Patients with Migraine during Attack and Attack-Free Periods. Cephalalgia, 41, 166-175. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Guo, S., Vollesen, A.L.H., Hansen, Y.B.L., Frandsen, E., Andersen, M.R., Amin, F.M., et al. (2016) Part II: Biochemical Changes after Pituitary Adenylate Cyclase-Activating Polypeptide-38 Infusion in Migraine Patients. Cephalalgia, 37, 136-147. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Liu, J., Wang, G., Dan, Y. and Liu, X. (2022) CGRP and PACAP-38 Play an Important Role in Diagnosing Pediatric Migraine. The Journal of Headache and Pain, 23, Article No. 68. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Pérez-Pereda, S., Toriello-Suárez, M., Ocejo-Vinyals, G., Guiral-Foz, S., Castillo-Obeso, J., Montes-Gómez, S., et al. (2020) Serum CGRP, VIP, and PACAP Usefulness in Migraine: A Case–control Study in Chronic Migraine Patients in Real Clinical Practice. Molecular Biology Reports, 47, 7125-7138. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Han, X., Dong, Z., Hou, L., Wan, D., Chen, M., Tang, W., et al. (2015) Interictal Plasma Pituitary Adenylate Cyclase-Activating Polypeptide Levels Are Decreased in Migraineurs but Remain Unchanged in Patients with Tension-Type Headache. Clinica Chimica Acta, 450, 151-154. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Tuka, B., Helyes, Z., Markovics, A., Bagoly, T., Szolcsányi, J., Szabó, N., et al. (2013) Alterations in PACAP-38-Like Immunoreactivity in the Plasma during Ictal and Interictal Periods of Migraine Patients. Cephalalgia, 33, 1085-1095. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Frederiksen, S.D., Bekker‐Nielsen Dunbar, M., Snoer, A.H., Deen, M. and Edvinsson, L. (2020) Serotonin and Neuropeptides in Blood from Episodic and Chronic Migraine and Cluster Headache Patients in Case‐Control and Case‐Crossover Settings: A Systematic Review and Meta‐analysis. Headache: The Journal of Head and Face Pain, 60, 1132-1164. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Russell, M.B. and Olesen, J. (1993) The Genetics of Migraine without Aura and Migraine with Aura. Cephalalgia, 13, 245-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Ziegler, D.K., Hur, Y., Bouchard, T.J., Hassanein, R.S. and Barter, R. (1998) Migraine in Twins Raised Together and Apart. Headache: The Journal of Head and Face Pain, 38, 417-422. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Russell, M.B. and Olesen, J. (1995) Increased Familial Risk and Evidence of Genetic Factor in Migraine. BMJ, 311, 541-544. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Russell, M., Iselius, L. and Olesen, J. (1995) Inheritance of Migraine Investigated by Complex Segregation Analysis. Human Genetics, 96, 726-730. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Stewart, W.F., Staffa, J., Lipton, R.B. and Ottman, R. (1997) Familial Risk of Migraine: A Population‐Based Study. Annals of Neurology, 41, 166-172. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Ulrich, V., Gervil, M., Kyvik, K.O., et al. J. (1999) The Inheritance of Migraine with Aura Estimated by Means of Structural Equation Modelling. Journal of Medical Genetics, 36, 225-227.
|
|
[60]
|
Ulrich, V., Gervil, M., Kyvik, K.O., Olesen, J. and Russell, M.B. (1999) Evidence of a Genetic Factor in Migraine with Aura: A Population-Based Danish Twin Study. Annals of Neurology, 45, 242-246. [Google Scholar] [CrossRef]
|
|
[61]
|
Polderman, T.J.C., Benyamin, B., de Leeuw, C.A., Sullivan, P.F., van Bochoven, A., Visscher, P.M., et al. (2015) Meta-analysis of the Heritability of Human Traits Based on Fifty Years of Twin Studies. Nature Genetics, 47, 702-709. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Russell, M., Iselius, L. and Olesen, J. (1996) Migraine without Aura and Migraine with Aura Are Inherited Disorders. Cephalalgia, 16, 305-309. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Stewart, W.F., Bigal, M.E., Kolodner, K., Dowson, A., Liberman, J.N. and Lipton, R.B. (2006) Familial Risk of Migraine. Neurology, 66, 344-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Russell, M.B., Ulrich, V., Gervil, M. and Olesen, J. (2002) Migraine without Aura and Migraine with Aura Are Distinct Disorders. a Population‐based Twin Survey: Variation by Proband Age at Onset and Headache Severity. Headache: The Journal of Head and Face Pain, 42, 332-336. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
D’Amico, D., Leone, M., Macciardi, F., Valentini, S. and Bussone, G. (1991) Genetic Transmission of Migraine without Aura: A Study of 68 Families. The Italian Journal of Neurological Sciences, 12, 581-584. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Mochi, M., Sangiorgi, S., Cortelli, P., Carelli, V., Scapoli, C., Crisci, M., et al. (1993) Testing Models for Genetic Determination in Migraine. Cephalalgia, 13, 389-394. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Gormley, P., Anttila, V., Winsvold, B.S., Palta, P., Esko, T., Pers, T.H., et al. (2016) Meta-Analysis of 375,000 Individuals Identifies 38 Susceptibility Loci for Migraine. Nature Genetics, 48, 856-866. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Wieser, T., Pascual, J., Oterino, A., Soso, M., Barmada, M. and Gardner, K.L. (2010) A Novel Locus for Familial Migraine on XP22. Headache: The Journal of Head and Face Pain, 50, 955-962. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Lea, R.A., Nyholt, D.R., Curtain, R.P., Ovcaric, M., Sciascia, R., Bellis, C., et al. (2005) A Genome-Wide Scan Provides Evidence for Loci Influencing a Severe Heritable Form of Common Migraine. Neurogenetics, 6, 67-72. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Wessman, M., Kallela, M., Kaunisto, M.A., Marttila, P., Sobel, E., Hartiala, J., et al. (2002) A Susceptibility Locus for Migraine with Aura, on Chromosome 4q24. The American Journal of Human Genetics, 70, 652-662. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Lea, R.A., Shepherd, G.A., Curtain, R.P., Nyholt, D.R., Quinlan, S., Brimage, P.J., et al. (2002) A Typical Migraine Susceptibility Region Localizes to Chromosome 1q31. Neurogenetics, 4, 17-22. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Hautakangas, H., Winsvold, B.S., Ruotsalainen, S.E., Bjornsdottir, G., Harder, A.V.E., Kogelman, L.J.A., et al. (2022) Genome-Wide Analysis of 102,084 Migraine Cases Identifies 123 Risk Loci and Subtype-Specific Risk Alleles. Nature Genetics, 54, 152-160. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Rasmussen, A.H., Kogelman, L.J.A., Kristensen, D.M., Chalmer, M.A., Olesen, J. and Hansen, T.F. (2020) Functional Gene Networks Reveal Distinct Mechanisms Segregating in Migraine Families. Brain, 143, 2945-2956. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Khan, J., Al Asoom, L., Al Sunni, A., Rafique, N., Latif, R., Alabdali, M., et al. (2022) Whole-exome Sequencing Reveals Migraine-Associated Novel Functional Variants in Arab Ancestry Females: A Pilot Study. Brain Sciences, 12, Article 1429. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Techlo, T.R., Rasmussen, A.H., Møller, P.L., Bøttcher, M., Winther, S., Davidsson, O.B., et al. (2020) Familial Analysis Reveals Rare Risk Variants for Migraine in Regulatory Regions. Neurogenetics, 21, 149-157. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Carvalho, E., Dias, A., Sousa, A., Lopes, A.M., Martins, S., Pinto, N., et al. (2022) A High Methylation Level of a Novel −284 bp CpG Island in the RAMP1 Gene Promoter Is Potentially Associated with Migraine in Women. Brain Sciences, 12, Article 526. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Khan, J., Asoom, L.I.A., Sunni, A.A., Rafique, N., Latif, R., Saif, S.A., et al. (2021) Genetics, Pathophysiology, Diagnosis, Treatment, Management, and Prevention of Migraine. Biomedicine & Pharmacotherapy, 139, Article ID: 111557. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
Giffin, N.J., Ruggiero, L., Lipton, R.B., Silberstein, S.D., Tvedskov, J.F., Olesen, J., et al. (2003) Premonitory Symptoms in Migraine. Neurology, 60, 935-940. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Maniyar, F.H., Sprenger, T., Monteith, T., Schankin, C. and Goadsby, P.J. (2013) Brain Activations in the Premonitory Phase of Nitroglycerin-Triggered Migraine Attacks. Brain, 137, 232-241. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
Lauritzen, M., Dreier, J.P., Fabricius, M., Hartings, J.A., Graf, R. and Strong, A.J. (2010) Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain Injury. Journal of Cerebral Blood Flow & Metabolism, 31, 17-35. [Google Scholar] [CrossRef] [PubMed]
|
|
[81]
|
Olesen, J., Larsen, B. and Lauritzen, M. (1981) Focal Hyperemia Followed by Spreading Oligemia and Impaired Activation of RCBF in Classic Migraine. Annals of Neurology, 9, 344-352. [Google Scholar] [CrossRef] [PubMed]
|
|
[82]
|
Charles, A. (2018) The Pathophysiology of Migraine: Implications for Clinical Management. The Lancet Neurology, 17, 174-182. [Google Scholar] [CrossRef] [PubMed]
|
|
[83]
|
Dodick, D.W. (2018) A Phase‐by‐phase Review of Migraine Pathophysiology. Headache: The Journal of Head and Face Pain, 58, 4-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[84]
|
Pavlovic, J.M., Buse, D.C., Sollars, C.M., Haut, S. and Lipton, R.B. (2014) Trigger Factors and Premonitory Features of Migraine Attacks: Summary of Studies. Headache: The Journal of Head and Face Pain, 54, 1670-1679. [Google Scholar] [CrossRef] [PubMed]
|